Mark G. Lebowhl, MD
Member of the Editorial Board
Doctor Mark Lebowhl graduated sum cum laude from Columbia College in New York in 1974 and received his MD in 1978 from Harvard Medical School in Boston. He completed residencies in both internal medicine and dermatology at Mount Sinai Hospital in New York. He is the Kimberly and Eric J. Waldman Professor and Chairman of the Kimberly and Eric J. Waldman Department of Dermatology of the Icahn School of Medicine at Mount Sinai.
Among his accomplishments are serving as President of the New York Dermatological Society, the Manhattan Dermatologic Society, and the New York State Society of Dermatology, ad well as Chairman of the Dermatology Section of the New York Academy of Medicine. He was elected to the Board of Directors of the American Academy of Dermatology (AAD) for 2010-2014 and served as the President in 2015-2016. For the AAD, he has been a member of the Scientific Assembly Council, chaired Academy 2001 in California, and chaired the AAD Annual Meeting in Washington, DC in 2004.
Doctor Lebwohl is Chairman Emeritus of the Medical Board of the National Psoriasis Foundation and is the Founding Editor of Psoriasis Forum and the Journal of Psoriasis and Psoriatic Arthritis. He is Editor of the Dermatology Section of Scientific American Medicine, formerly ACP Medicine. He has chaired numerous symposia and has written, edited, or co-edited several books, including the first atlas devoted entirely to cutaneous manifestations of systemic disease, and the leading book on dermatologic therapy, Treatment of Skin Disease. The second edition of The Skin and Systemic Disease has been published in both English and French, while English, Chinese, Portuguese, and Polish versions of Treatment of Skin Disease are available. Other books include Difficult Diagnoses in Dermatology and Psoriasis, Mild-to-Moderate Psoriasis and Moderate-to-Severe Psoriasis. He has authored or co-authored over 500 publications including peer-reviewed contributions, invited papers, and book chapters. Doctor Lebwohl is actively involved in clinical trials of many new dermatologic treatments.